The neutrophilic dermatoses.
The neutrophilic dermatoses (ND) may present with pustules, plaques, ulcerations, and general malaise. They are secondary to the invasion of the skin by normal polymorphonuclear leukocytes in the absence of infection. ND are often associated with particular systemic diseases. The management of affected patients is reviewed, with a focus on nursing care.
Farhi
David
D
Dermatology and Venereology Department, Tarnier-Cochin Hospital, Paris, France.
Wallach
Daniel
D
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001706:Biopsy; D016572:Cyclosporine / Q000627:therapeutic use; D003622:Dapsone / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000627:therapeutic use; D003937:Diagnosis, Differential; D006652:Histological Techniques; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000069285:Infliximab; D008487:Medical History Taking; D020556:Neutrophil Infiltration; D010353:Patient Education as Topic; D017511:Pyoderma Gangrenosum / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D017592:Skin Care / Q000379:methods; D012872:Skin Diseases, Vesiculobullous / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D016463:Sweet Syndrome / Q000175:diagnosis / Q000209:etiology / Q000628:therapy
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003622:Dapsone; D000069285:Infliximab